Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Olmesartan franchise

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.

Alexion eyes Soliris combo with $930m deal to buy Achillion

Alexion eyes Soliris combo with $930m deal to buy Achillion

Meanwhile, for Achillion the takeover by Alexion marks a renaissance for the company, which had to reinvent itself after a once-promising  hepatitis C virus franchise faded away, taking partner Johnson

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

Gilead promotes Andrew Dickinson to CFO, increased M&A expected The new CEO is focused on steering Gilead away from relying on its HIV franchise, as it looks to expand into immuno-oncology and other lucrative therapy areas.

FDA approves Lilly’s migraine drug Reyvow

FDA approves Lilly’s migraine drug Reyvow Reyvow will join another recently approved migraine product, the CGRP antagonist Emgality, in Lilly’s franchise.

Gilead builds case for Xeljanz rival filgotinib as it preps US filing

Gilead builds case for Xeljanz rival filgotinib as it preps US filing its HIV franchise, to include new areas like cancer, liver disease and immunology.

Novo Nordisk, bluebird team up to develop haemophilia A therapies

Novo Nordisk, bluebird team up to develop haemophilia A therapies s key diabetes franchise is also under pressure.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics